Amicus Therapeutics CEO and leadership

John Francis Crowley (born April 7, 1967) is an American biotechnology executive and entrepreneur and the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme Corporation, and founded Orexigen Therapeutics. In 2006, he was profiled in the book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children by Geeta Anand. In 2010, Crowley released his memoir, Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. Crowley and his family were the inspiration for the movie Extraordinary Measures starring Harrison Ford and Brendan Fraser in 2010.

Bradley L. Campbell joined Amicus in May 2006 and currently serves as Chief Operating Officer. He brings 15 years of experience in the biotech and pharmaceutical industries. Prior to Amicus, Mr. Campbell was with Genzyme Corporation, where he first served as Sr. Product Manager for Myozyme®, an enzyme replacement therapy for Pompe disease. He then became a Business Director in Genzyme Cardiovascular, responsible for business development, alliance management and commercial planning for their cardiac gene therapy programs. Mr. Campbell has also worked in sales & marketing for Bristol-Myers Squibb and as a business strategy consultant for Marakon Associates.

Daphne Quimi is a Chief Financial Officer at AMICUS THERAPEUTICS INC and is based in Greater New York City Area. She has worked as Dir:Acctg Policy at AMICUS THERAPEUTICS INC; Auditor/Senior Auditor at KPMG US; and Director, Consolidations & External Reporting (Corporate) at Johnson & Johnson. Daphne works or has worked as MEMBER at Institute of Management Accountants Inc and MEMBER at AICPA. She attended Monmouth University between 1985 and 1988, Stern School Of Business between 1995 and 1998, and New York University.

David Clark is the Chief People Officer at Amicus Therapeutics. David has been a leader in human resources and talent development for more than two decades. His expertise is in leadership development, performance management, driving business results and large-scale complex change. David joined Amicus in October 2018 after two years as Vice President of Global Human Resources at Alibaba Group in Hangzhou, China. Prior to that, David spent eight years at American Express, where he was Senior Vice President of HR and Chief Learning Officer. While there, David was a senior HR Business Partner and led the transformation of learning and leadership development and performance management. Previously, David was a Commissioned Officer on the White House senior staff. As Deputy Assistant to the President of the United States, he led the recruitment and development of the 4,000 most senior leaders in the U.S. government. David received a B.S. in political science from Indiana State University. He is an Eagle Scout and serves on the National Executive Board of the Boy Scouts of America (BSA). David is also the Chairman of the Board of the Make-A-Wish Foundation of America.

I joined Amicus Therapeutics in February of 2016 and currently serve as Chief Legal Officer. In this role, I am responsible for all legal matters for this growing biotech company, including intellectual property, transactions, corporate governance, SEC compliance, US and International commercial guidance, litigation, employment matters, government affairs and overall risk assessment and mitigation. I am also responsible for all board of directors and board committee matters. I also bring significant legal experience in the biopharmaceutical and medical device industry including mergers and acquisitions, product launches, investigations, litigation risk management, and compliance matters. Prior to joining Amicus, I served as Senior Vice President, Associate General Counsel of Shire Pharmaceuticals. Prior to Shire, I served as Associate General Counsel for the Metabolic Endocrinology division at EMD Serono Inc., the U.S. affiliate of Merck KGaA.

I received a B.A. from the University of Connecticut and a J.D. from the University of Pennsylvania Law School.

Rare disease drug development professional with expertise in program management, clinical development, regulatory strategy, and portfolio planning.

• 17 years of pharmaceutical/biotechnology drug development with focus in rare diseases

• Experience managing cross-functional teams from preclinical development through global regulatory submissions

• Founding member of program management department within a venture-backed biotech company that is now a global fully-integrated rare disease market leader

• Passionate rare disease drug developer with high energy and team-oriented personality

Patrik Florencio is a Senior VP/Global Chief Compliance & Risk Officer at AMICUS THERAPEUTICS INC and is based in New York City, New York. He has worked as SVP, Global Chief Compliance and Risk Officer at AMICUS THERAPEUTICS INC; VP, Chief Corporate Compliance Officer for North America at Sandoz; and Healthcare Associate at Ropes & Gray. Patrik studied at McGill University between 1993 and 1997.

John Francis Crowley (born April 7, 1967) is an American biotechnology executive and entrepreneur and the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme Corporation, and founded Orexigen Therapeutics. In 2006, he was profiled in the book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children by Geeta Anand. In 2010, Crowley released his memoir, Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. Crowley and his family were the inspiration for the movie Extraordinary Measures starring Harrison Ford and Brendan Fraser in 2010.

John Francis Crowley (born April 7, 1967) is an American biotechnology executive and entrepreneur and the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme Corporation, and founded Orexigen Therapeutics. In 2006, he was profiled in the book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children by Geeta Anand. In 2010, Crowley released his memoir, Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. Crowley and his family were the inspiration for the movie Extraordinary Measures starring Harrison Ford and Brendan Fraser in 2010.

Bradley L. Campbell joined Amicus in May 2006 and currently serves as Chief Operating Officer. He brings 15 years of experience in the biotech and pharmaceutical industries. Prior to Amicus, Mr. Campbell was with Genzyme Corporation, where he first served as Sr. Product Manager for Myozyme®, an enzyme replacement therapy for Pompe disease. He then became a Business Director in Genzyme Cardiovascular, responsible for business development, alliance management and commercial planning for their cardiac gene therapy programs. Mr. Campbell has also worked in sales & marketing for Bristol-Myers Squibb and as a business strategy consultant for Marakon Associates.